Drug Profile
Research programme: type 2 diabetes mellitus therapeutics - Albireo AB
Alternative Names: IBAT inhibitor (for T2DM) - AlbireoLatest Information Update: 01 Mar 2017
Price :
$50
*
At a glance
- Originator Albireo AB
- Class
- Mechanism of Action Sodium-bile acid cotransporter inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Type 2 diabetes mellitus
Most Recent Events
- 01 Mar 2017 Discontinued - Preclinical for Type-2 diabetes mellitus in Sweden (unspecified route) before March 2017
- 18 Dec 2014 Preclinical trials in Type-2 diabetes mellitus in Sweden (unspecified route)